Premium
Treatment of aortic stenosis in patients with chronic liver disease: Another win for transfemoral TAVR?
Author(s) -
Tarantini Giuseppe,
Nai Fovino Luca
Publication year - 2020
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.28690
Subject(s) - medicine , valve replacement , stenosis , aortic valve replacement , cardiology , aortic valve stenosis , risk stratification , surgery
Key Points Chronic liver disease is associated with increased operative risk of open‐heart surgery. In this study, transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) carried high periprocedural mortality, but transfemoral TAVR appeared to be superior to SAVR in terms of long‐term survival. Better risk stratification tools are needed for patients with liver dysfunction to avoid futile TAVR and SAVR procedures.